You are currently browsing the daretwocare.com weblog archives for the day Sunday, December 30th, 2007.
Global warming to alter Calif. landscapeEly Times, USA -4 minutes agoBy NOAKI SCHWARTZ, AP Writer Sat Dec 29, 3:04 PM ET LOS ANGELES - California is defined by its scenery, from the mountains that enchanted John Muir to the …
More: continued here
(SPRINGFIELD, Mo.) — From socks to cars and everything in between, an area organization is doing its part to help save the environment and the focus of that effort lies online.
More: continued here
Scotland’s environment secretary calls for a review of export controls to stop the spread of bluetongue disease.
More: continued here
The Tennessee Lady Vols tend to draw a crowd wherever they go. On the road, that often means a hostile crowd and lots of noise.
More: continued here
Science & environment: Archbishop of Canterbury says God ‘does not do waste’ in green new year message released on YouTube
More: continued here
Ross Selected To Global Warming DelegationSpringdale Morning News, AR -Dec 29, 2007Mike Ross, D-Prescott, has been selected to the bipartisan congressional delegation on global warming, and will travel to Antarctica and Australia. …
More: continued here
A biology professor at Lycoming College, Mel Zimmerman said his interest in environmental issues began early and translated into a career and involvement in the same topics as an adult.
More: continued here
Global warming … or just a lot of hot air?St. Petersburg Times, FL -17 hours agoCharlie Crist's belief that global warming is a threat to Florida and the world. Shortly before Christmas, McCollum sent a memo to Crist and the other …
More: continued here
There is no quick remedy for what ails the pharmaceutical industry: a tougher environment for drug approvals and a dwindling pipeline of new medications. But these twin challenges _ evidence that the heyday of blockbuster drug-development is over _ are… [...]
There is no quick remedy for what ails the pharmaceutical industry: a tougher environment for drug approvals and a dwindling pipeline of new medications.
More: continued here
